The Valley Desk

NCT05634369 · Interventional trial

A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov